Laninamivir Octanoate

• CAT Number: R050807
• CAS Number: 203120-46-1
• Molecular Formula: C21H36N4O8
• Molecular Weight: 472.53
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-2-hydroxy-1-methoxy-3-octanoyloxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
• InChI: InChI=1S/C21H36N4O8/c1-4-5-6-7-8-9-16(28)32-11-14(27)18(31-3)19-17(24-12(2)26)13(25-21(22)23)10-15(33-19)20(29)30/h10,13-14,17-19,27H,4-9,11H2,1-3H3,(H,24,26)(H,29,30)(H4,22,23,25)/t13-,14+,17+,18+,19+/m0/s1
• InChIKey: UKTIJASCFRNWCB-RMIBSVFLSA-N
• SMILES: CCCCCCCC(=O)OCC(C(C1C(C(C=C(O1)C(=O)O)N=C(N)N)NC(=O)C)OC)O

Laninamivir octanoate (Cat No.:R050807) is a prodrug of Laninamivir (R-125489), an antiviral agent known for its exceptional neuraminidase (NA) inhibitory activity against influenza viruses. Laninamivir exhibits a long-lasting effect, making it a potent treatment option for influenza infections. As a prodrug, Laninamivir octanoate is converted into its active form, Laninamivir, within the body. This drug’s extended anti-influenza activity and ease of administration have led to its use in some regions as an effective treatment for influenza.